The future of best investing in vaccines: the Health Technology Assessment approach.
Over the past two decades, scientific research has led to the development of a huge number of new health technologies, among which new vaccines. The decision process underlying the introduction of a new vaccine will be of particular concern in the future and a useful tool is needed to orientate decision makers towards better allocation of economic resources. Health Technology Assessment (HTA) is a multidisciplinary tool that aims to examine the clinical, economic, organizational, ethical, juridical, social and cultural implications of the introduction or the implementation of a specific technology; it could so represent an innovative and effective approach in order to support decision-making processes.
La Torre
Giuseppe
G
Institute of Hygiene, Catholic University of the Sacred Heart, Rome, Italy. giuseppe.latorre@rm.unicatt.it
de Waure
Chiara
C
Chiaradia
Giacomina
G
Mannocci
Alice
A
Specchia
Maria Lucia
ML
Nicolotti
Nicola
N
Ricciardi
Walter
W
D020811:Biomedical Technology / Q000191:economics* / Q000639:trends*; D004345:Drug Industry / Q000191:economics* / Q000639:trends*; D017048:Health Care Costs; D005102:Health Expenditures; D006801:Humans; D017053:Infection Control / Q000191:economics / Q000639:trends; D014612:Vaccines / Q000191:economics*
D014612:Vaccines